Nation Jul 31

U.S. sinks another $2.1 billion into a potential vaccine

Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of its experimental COVID-19 vaccine to the United States as drugmakers scramble to develop drugs to stem the pandemic.

The Latest